Patent US4705789A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4705789A Expired / Lapsed US ⏱️ 0.0 years remaining

Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids

Assignee: Bayer AG
•
Filing: 1984-08-27
•
Granted: 1987-11-10
•
Expires: 2004-08-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to solutions of piperazinyl-quinolone- and piperazinyl-azaquinolone-carboxylic acids, and in particular both ready-to-use injection and/or infusion solutions and dosage forms which can be converted into such injection and/or infusion solutions before use. The solutions according to the invention are characterized in that, besides the lactic acid salts of the active substance and, if appropriate, customary auxiliaries, they additionally contain at least one acid which does not lead to precipitates, in particular lactic acid.

Inventors

  • 👤 Klaus Grohe
  • 👤 Robert Lammens

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 12:31
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04; A; A61; A61K; A61K47/00; A61K47/06; A61K47/08; A61K47/12; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/535; A61K9/00; A61K9/0012; A61K9/0019; A61K9/08; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 101 words
An aqueous storage stable solution which can be converted into injection or diffusion solution, comprising a solution of (a) a lactic acid salt of at least one of a piperazinylquinolone- and a piperazinyl containing azaquinoline-carboxylic acid of the formula I and II ##STR2## in which X denotes N, C--H or C--F, Z denotes CH 2 , R 1 denotes hydrogen, methyl, ethyl or β-hydroxyethyl, R 2 denotes cyclopropyl or ethyl and R 3 denotes hydrogen, methyl or ethyl, and (b) excess lactic acid, the excess lactic acid being present in from 0.01 to 90% of the amount based on the solution.
Claim 2
Dependent Claim 101 words
An aqueous storage stable solution which can be converted into injection or diffusion solution, comprising a solution of (a) a lactic acid salt of at least one of a piperazinylquinolone- and a piperazinyl containing azaquinoline-carboxylic acid of the formula I and II ##STR2## in which X denotes N, C--H or C--F, Z denotes CH 2 , R 1 denotes hydrogen, methyl, ethyl or β-hydroxyethyl, R 2 denotes cyclopropyl or ethyl and R 3 denotes hydrogen, methyl or ethyl, and (b) excess lactic acid, the excess lactic acid being present in from 0.01 to 90% of the amount based on the solution.
Claim 3
Dependent Claim 12 words
A solution according to claim 1 additionally containing a non-toxic pharmaceutical carrier.
Claim 4
Dependent Claim 18 words
A solution according to claim 1, which contains the lactate of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid as the lactic acid salt.
Claim 5
Dependent Claim 13 words
A solution according to claim 1, which contains the lactate of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid.
Claim 6
Dependent Claim 13 words
A solution according to claim 1, which contains the lactate of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl-1,8-naphthyridine-3-carboxylic acid.
Claim 7
Dependent Claim 17 words
A solution according to claim 1, which the content of excess lactic acid is 0.01 to 2.5%.
Claim 8
Dependent Claim 18 words
A solution according to claim 1, in which the content of excess lactic acid is 0.01 to 1.4%.

References Cited (Backward Citations)

DE296839C Cited
US4022894A Cited
EP0009425A1 Cited
DE2918319A1 Cited
DE3037103A1 Cited
EP0047005B1 Cited
EP0067666A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-11-09 1991-05-11 1991-11-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-11-09 1995-05-11 1995-11-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-11-09 1999-05-11 1999-11-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag